Tandem Diabetes Care Inc. (TNDM) Plunges 5.31% on February 22

0
414

Market overview

consequences

Tandem Diabetes Care Inc. is a medical device company that develops products for people with insulin-dependent diabetes. The company has three major insulin pump products.

Last price
$ 92.89
Last trade

February 22nd – 4:00 p.m.

change
$ -5.21
Percent change
-5.31%
to open
$ 97.00
Back Close
$ 98.10
High
$ 97.46
low
$ 92.70
52 week high
$ 123.74
52 weeks low
$ 43.69
Market capitalization
5,777,257,230
PE ratio
17.69
volume
887.889
exchange
NSD

TNDM – Market Data & News

trade

Tandem Diabetes Care Inc. (TNDM) had a tough trading day on Monday, February 22nd, when shares fell 5.31%, or a loss of $ -5.21 per share, to close at $ 92.89. After opening the day at $ 97.00, shares of Tandem Diabetes Care Inc. were trading at $ 97.46 and $ 92.70, respectively. The volume was 887,592 shares over 10,794 trades, versus an average daily volume of 100,000 shares and a total float of 62.19 million.

As a result of the decline, Tandem Diabetes Care Inc. now has a market capitalization of $ 5.78 billion. Last year, shares in Tandem Diabetes Care Inc. traded between $ 123.74 and $ 43.69. The 50-day SMA is currently n / a and the 200-day SMA is n / a.

For a complete in-depth analysis from Tandem Diabetes Care Inc., see Equities.com’s Stock Valuation Analysis report for TNDM.

Do you still pay commissions on stock trades? Equities.com now offers unlimited trading for $ 7.99 / month and flat options for $ 89.99 / month! Get started today at https://www.equities.com/trading-start

Tandem Diabetes Care Inc is a medical device company that develops products for people with insulin-dependent diabetes. The company has three major insulin pump products. The t: slim Insulin Delivery System fits easily into a user’s pocket. The t: flex insulin delivery system is used by customers with higher insulin needs. The t: slim G4 insulin delivery system is a pump with continuous glucose monitoring and a touchscreen. Tandem Diabetes also sells pump-related consumables and accessories. Pump sales make up the bulk of sales. Virtually all of its sales are in the United States.

Tandem Diabetes Care Inc. is based in San Diego, California and employs approximately 1,043 people. Its CEO is John F. Sheridan.

Tandem Diabetes Care Inc. is a component of the Russell 2000. The Russell 2000 is one of the leading indices for small-cap companies in the United States. Managed by Russell Investments, an industry leader in index creation and maintenance, it is made up of the smallest 2000 stocks from the broader Russell 3000 index.

Russell’s indices differ from traditional indices such as the Dow Jones Industrial Average (DJIA) or the S&P 500, whose members are selected by the committee because they are based solely on an objective, rule-based methodology. The 3,000 largest companies by market cap make up the Russell 3000 and the 2,000 smaller companies make up the Russell 2000. This is a simple approach that offers a comprehensive, unbiased look at the small-cap market as a whole.

For more information about Tandem Diabetes Care Inc. and to keep track of the latest updates from the company, please visit the company’s profile page here: TNDM’s Profile. For more news on the financial markets and emerging growth companies, visit the Equities.com news desk. Also, don’t forget to sign up for our daily email newsletter to make sure you don’t miss any of our best stories.

All data was provided by QuoteMedia and was correct as of 4:30 p.m. ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors and do not reflect those of equities.com. Readers should not regard statements made by the author as a formal recommendation and should consult their financial advisor before making any investment decisions. Our full disclosure is available at: http://www.equities.com/disclaimer

Next page